Ad www.AngelOne.in
FREE Account Opening + Zero AMC Fees* + MutualFund SIP1
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Ad www.AngelOne.in
Right Issue Status: Closed [15th Feb 2023 to 28th Feb 2023]
Shukra Pharmaceuticals Limited offers Right Issue size of Rs 18.79 Cr. Opening subscription from 15 Feb 2023 to 28 Feb 2023. The company issues 06 right equity shares for every 01 equity shares held on the record date of, 02 Feb 2023. The face value of a share is Rs. 10 per share and the right issue price is fixed at Rs. 20 per share. Stay updated with us to know more about the Shukra Pharmaceuticals Limited Right Issue Details 2022 including issue size, right issue entitlement, terms of payment, and more.
The Company proposes to utilize the Net Proceeds to:
| Shukra Pharmaceuticals Issue Details | Values |
|---|---|
| Category | RightIssue |
| Right Issue Issue Size (Shares) | 0.94 Cr Shares |
| Right Issue Issue Size (Amount) | ₹18.79 Cr |
| Face Value | ₹10 Per Equity Share |
| Right Issue - Issue Price | ₹20 per share |
| Right Issue Record Date | 2nd Feb 2023 |
| Right Issue Entitlement | 6 Equity Shares for every 1 Fully Paid Equity Share held |
| Right Issue Terms of payment | Rs. 5 per Rights Equity Share to be paid on Application and balance to be paid in three calls as determined. |
| Listing At | BSE |
| BSE Code | 524632 |
| NSE Code |
In this section we have covered all important dates related to Shukra Pharmaceuticals Right Issue. Dates are updated as they are announced. The most noted dates are Right Issue start date and Right Issue end date, which one should use to participate in Right Issue.
| Right Issue Activity | Date |
|---|---|
| Right Issue Issue Open Date | 15th Feb 2023 |
| Right Issue Issue Close Date | 28th Feb 2023 |
| Basis of Allotment Finalisation Date* | 8th Mar 2023 |
| Refunds Initiation* | 23rd Feb 2023 |
| Credit of Shares to Demat Account* | 14th Mar 2023 |
| Right Issue Listing Date* | 15th Mar 2023 |
* - Tentative Dates
Zerodha Trade@20
This company was incorporated on March 4, 1993 as a private limited company with the name Relish Pharmaceuticals Pvt Ltd. The Shukra Pharmaceuticals is an ambitious organization with a deep rooted focus on sustainability with our impressive range of solutions. They are committed to deliver excellence across National & Global markets. Shukra Pharmaceuticals is a public limited organization with globally acclaimed manufacturing facilities.
Its product portfolio includes Antibiotics (Penicillin) Anti Biotic (Cephalosporin) Anti Biotic Macrolides Quinolones Anti-Bacterial Anti-Fungal Anti-Malarial Anti-Viral Anti Protozoan Anti Anthelmintic Sedative and Tranquillizer Anti-Depressant Anti Manic Anti Emetic Anti-Ulcer Beta Blockers Diuretics Analgesic (NASID) Muscle Relaxants Anti Tuberculosis Vitamin Products Anti Allergic Corticosteroids Hyper and Hypoglycemic Others.
The Shukra Pharma boast fully integrated structure for manufacturing general formulations like Tablet, Capsules and small volume parenteral since 2017. They aim to go beyond developing products and provide complete solutions, in fact we harness science and technology to develop products for healthy and safe living.
Past performance and financial results of Shukra Pharmaceuticals.
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth |
|---|---|---|---|---|
| 31-Mar-21 | 35.61 | 11.55 | 0.19 | 15.60 |
| 31-Mar-22 | 35.11 | 20.57 | 0.75 | 16.35 |
| Amount in ₹ Crore | ||||
The table below is live update of Right Issue bidding details from NSE and BSE.
Shukra Pharmaceuticals Right Issue Offer Document (Letter of Offer) >>Document
Shukra Pharmaceuticals Right Issue Offer Document (Letter of Offer) >>Shukra Pharmaceuticals Right Issue Red Herring Prospectus is not yet available.
Shukra Pharmaceuticals Right Issue Online Application (Registrar & Transfer Agent) >>Online Application
Shukra Pharmaceuticals Right Issue Online Application (Registrar & Transfer Agent) >>Shukra Pharmaceuticals Right Issue RTA information is not yet available.
Last Updated on 2023-03-03T02:30:51+00:00
